Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > I am exhausted listing to the complaining here.

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 14, 2021 5:54pm

142 Views

Post# 32302582

RE:RE:RE:RE:I am exhausted listing to the complaining here.

So he knows who bought the 14 million Units,,,WOW

Bucknelly21 wrote: I emailed Phillipe about where the shares would be going and how do we know that they won't get sold after the 19th for a .10 profit. His response was "the people we sold it to are not in it for the short term or to flip the shares, they see the potential and will be there for a while"

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program